Dr. Garzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1950 Circle of Hope Dr 4126
Salt Lake City, UT 84112Phone+1 801-581-2121Fax+1 614-293-7526
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2002 - 2005
- Danbury HospitalResidency, Internal Medicine, 1999 - 2002
- Universidad Nacional de CordobaClass of 1994
Certifications & Licensure
- UT State Medical License 2022 - 2026
- OH State Medical License 2005 - 2023
- PA State Medical License 2002 - 2006
Clinical Trials
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease Start of enrollment: 2012 Feb 20
- AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Sep 17
- Join now to see all
Publications & Presentations
PubMed
- Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia.Chinmayee Goda, Rohan Kulkarni, Yaphet Bustos, Wenjun Li, Alexander Rudich
Leukemia. 2024-10-02 - 2 citationsCRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model.Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, Yandi Gao, Rathan Kumar
Blood Advances. 2024-02-27 - 4 citationsPhase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani
Leukemia & Lymphoma. 2023-12-01
Abstracts/Posters
- Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML)Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leuke...Ramiro Garzon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Long Noncoding RNAs: Novel Prognostic Marker in Older Patients with Acute LeukemiaDecember 15th, 2014
- Inhibitors of Shuttle Molecule Show Promise in Acute LeukemiaJune 19th, 2012
- Huntsman Cancer Institute Researchers Find Link Between Folic Acid and Blood Cell ProductionDecember 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: